SCHEMBL18456430

SCHEMBL18456430

Cc1ccc(-c2cc(=O)c3c(C)c(O)c(O)c(C)c3o2)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.50
▸ PARP2 Q9UGN5 1/20 0.50
▸ MAPT P10636 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ POLB P06746 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ RECQL P46063 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ INPPL1 O15357 1/20 0.48
▸ ALPL P05186 1/20 0.48
▸ ALPI P09923 1/20 0.48
▸ ALPG P10696 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ APEX1 P27695 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ MCL1 Q07820 1/20 0.48
▸ PFKFB3 Q16875 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ CSNK2A2 P19784 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18462964 0.85 AR (0.57) PARP1PARP2MAPTKDM4EPOLB
SCHEMBL20718935 0.78 ABCB1 (0.71) PARP1PARP2MAPTKDM4EPOLB
SCHEMBL13955211 0.76 TP53 (0.57) PARP1PARP2MAPTPKMCSNK2A2
SCHEMBL28009934 0.76 TERT (0.58) PARP1MAPTKDM4EPOLBGAA
SCHEMBL30269735 0.75 KMT2A (0.68) PARP1MAPTKDM4EPOLBGAA
SCHEMBL29615754 0.75 KMT2A (0.68) PARP1MAPTKDM4EPOLBGAA
SCHEMBL10013320 0.72 ABCB1 (0.64) MAPTKDM4EPOLBGAARECQL
SCHEMBL30956242 0.72 ALDH1A1 (0.70) MAPTKDM4EPOLBGAARECQL
SCHEMBL3320910 0.72 ALDH1A1 (0.70) MAPTKDM4EPOLBGAARECQL
SCHEMBL13479744 0.71 CSNK2A2 (0.64) PARP1PARP2MAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9808477-B2 Use of nobiletin in cancer treatment MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-11-07 — — US disclosed
US-20170143668-A1 USE OF NOBILETIN IN CANCER TREATMENT MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-05-25 — — US disclosed
US-20170027901-A1 USE OF NOBILETIN IN CANCER TREATMENT MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2017-02-02 — — US disclosed
Send feedback